Pliant Therapeutics, Inc., a late─stage biopharmaceutical company and leader in the discovery and development of novel therapeutics for the...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - NEWS.MEDICAL.NET - A la Une - Hier 04:37
Harbour BioMed partners with Insilico to accelerate AI-powered antibody discovery
Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, and Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, today announced a strategic collaboration to accelerate the discovery and development of innovative therapeutic antibodies, leveraging their respective technological strengths in antibody discovery and artificial intelligence.
Articles similaires
New Ebola virus research boosts pandemic preparedness
caribbeannewsglobal.com - 20/Feb 22:56
Promising antibody may prove useful against deadly outbreaks La Jolla Institute for Immunology LA JOLLA, USA — New research led by scientists at La...
ProfitShare Partners aligns with global AI trends
rwrant.co.za - 17/Feb 08:00
As artificial intelligence (AI) reshapes industries worldwide, fintech companies are leveraging AI-driven technologies to streamline lending, enhance...
New human antibody shows promise for Ebola virus treatment
news.medical.net - 04:47
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to...
China’s Quantum Strategy and The Threat of Global Data-Centric Authoritarianism
thequantumdaily.com - 15/Feb 12:05
Insider Brief China’s progress in quantum computing and communications could undermine encryption standards and accelerate the global spread of...
The Big Tech and the race for AI: a $320 billion investment that challenges efficiency
cryptonomist.ch - 12/Feb 13:15
The major Big Tech companies are allocating enormous financial resources to the development of artificial intelligence (AI).
Future of Healthcare: AI in Disease Prevention (and) Personalized Medicine
medindia.net - 15/Feb 08:10
Artificial intelligence is transforming healthcare by leveraging predictive analytics for early disease detection, ensuring efficient and ethical...
Les derniers communiqués
-
Aucun élément